Acute Myocardial Infarction

Cardiovascular·MeSH: Shock, Cardiogenic

6 drugs in development·6 companies·4 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
Hearticellgram-AMI	CYTOKINETICS INC (CYTK)
Hearticellgram-AMI	Cidara Therapeutics, Inc. (CDTX)

Phase 2(1)

Drug	Company
selatogrel	Innovation Pharmaceuticals Inc. (IPIX)

Phase 1(2)

Drug	Company
adipocell	U.S. Stem Cell, Inc. (USRM)
selatogrel	Viatris Inc (VTRS)

Preclinical(1)

Drug	Company
Instaprin	Aspire Biopharma Holdings Inc. (ASBP)

BioSniper tracks 6 drugs in development for Acute Myocardial Infarction across 6 companies.

There are 4 clinical trials targeting Acute Myocardial Infarction tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.